Ustekinumab treatment for hidradenitis suppurativa
Author:
Affiliation:
1. Departments ofDepartment of DermatologyTohoku University Graduate School of MedicineSendai Japan
2. Department of Gastroenterology Tohoku University Graduate School of Medicine Sendai Japan
Publisher
Wiley
Subject
Dermatology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15122
Reference15 articles.
1. Hidradenitis suppurativa
2. Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study
3. The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease
4. Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severity
5. Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ustekinumab: In Psoriasis and Beyond —A Derm atological Perspective;Journal of Pharmacology and Pharmacotherapeutics;2024-05-08
2. Polish guidelines for the diagnosis and treatment of hidradenitis suppurativa;Dermatology Review;2024
3. New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review;The Journal of Dermatology;2023-11-27
4. Therapeutic effect of ustekinumab on patients with extra-intestinal manifestations of Crohn’s disease;Expert Review of Gastroenterology & Hepatology;2023-03-24
5. The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease;Digestive and Liver Disease;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3